nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0837	0.126	CbGbCtD
Tolcapone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0787	0.118	CbGbCtD
Tolcapone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0787	0.118	CbGbCtD
Tolcapone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0711	0.107	CbGbCtD
Tolcapone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0711	0.107	CbGbCtD
Tolcapone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0614	0.0925	CbGbCtD
Tolcapone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0596	0.0898	CbGbCtD
Tolcapone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0539	0.0812	CbGbCtD
Tolcapone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0539	0.0812	CbGbCtD
Tolcapone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0517	0.0779	CbGbCtD
Tolcapone—COMT—blood plasma—acquired immunodeficiency syndrome	0.00343	0.18	CbGeAlD
Tolcapone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.0018	0.0947	CbGeAlD
Tolcapone—COMT—skin of body—acquired immunodeficiency syndrome	0.00165	0.0866	CbGeAlD
Tolcapone—COMT—digestive system—acquired immunodeficiency syndrome	0.00132	0.0693	CbGeAlD
Tolcapone—COMT—blood—acquired immunodeficiency syndrome	0.00126	0.066	CbGeAlD
Tolcapone—COMT—bone marrow—acquired immunodeficiency syndrome	0.00122	0.0639	CbGeAlD
Tolcapone—COMT—spinal cord—acquired immunodeficiency syndrome	0.00121	0.0636	CbGeAlD
Tolcapone—COMT—vagina—acquired immunodeficiency syndrome	0.00116	0.0612	CbGeAlD
Tolcapone—COMT—lung—acquired immunodeficiency syndrome	0.0011	0.0579	CbGeAlD
Tolcapone—COMT—nervous system—acquired immunodeficiency syndrome	0.00102	0.0536	CbGeAlD
Tolcapone—COMT—central nervous system—acquired immunodeficiency syndrome	0.000981	0.0516	CbGeAlD
Tolcapone—COMT—brain—acquired immunodeficiency syndrome	0.000779	0.041	CbGeAlD
Tolcapone—COMT—lymph node—acquired immunodeficiency syndrome	0.000753	0.0396	CbGeAlD
Tolcapone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000693	0.0364	CbGeAlD
Tolcapone—CYP2C9—blood—acquired immunodeficiency syndrome	0.00066	0.0347	CbGeAlD
Tolcapone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000154	0.000484	CcSEcCtD
Tolcapone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000484	CcSEcCtD
Tolcapone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000483	CcSEcCtD
Tolcapone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000483	CcSEcCtD
Tolcapone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000483	CcSEcCtD
Tolcapone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000483	CcSEcCtD
Tolcapone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000481	CcSEcCtD
Tolcapone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000481	CcSEcCtD
Tolcapone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000481	CcSEcCtD
Tolcapone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00048	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00048	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000478	CcSEcCtD
Tolcapone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000151	0.000478	CcSEcCtD
Tolcapone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000477	CcSEcCtD
Tolcapone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000477	CcSEcCtD
Tolcapone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000477	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.000477	CcSEcCtD
Tolcapone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000476	CcSEcCtD
Tolcapone—Pain—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000474	CcSEcCtD
Tolcapone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000474	CcSEcCtD
Tolcapone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000473	CcSEcCtD
Tolcapone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000472	CcSEcCtD
Tolcapone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000471	CcSEcCtD
Tolcapone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000471	CcSEcCtD
Tolcapone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000471	CcSEcCtD
Tolcapone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.00047	CcSEcCtD
Tolcapone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.00047	CcSEcCtD
Tolcapone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00047	CcSEcCtD
Tolcapone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000149	0.000469	CcSEcCtD
Tolcapone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000149	0.000469	CcSEcCtD
Tolcapone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000468	CcSEcCtD
Tolcapone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000468	CcSEcCtD
Tolcapone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000467	CcSEcCtD
Tolcapone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000467	CcSEcCtD
Tolcapone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000466	CcSEcCtD
Tolcapone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000465	CcSEcCtD
Tolcapone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000465	CcSEcCtD
Tolcapone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000465	CcSEcCtD
Tolcapone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000465	CcSEcCtD
Tolcapone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000463	CcSEcCtD
Tolcapone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000463	CcSEcCtD
Tolcapone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000462	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000462	CcSEcCtD
Tolcapone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000461	CcSEcCtD
Tolcapone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000459	CcSEcCtD
Tolcapone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000458	CcSEcCtD
Tolcapone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000456	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000456	CcSEcCtD
Tolcapone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000455	CcSEcCtD
Tolcapone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.000455	CcSEcCtD
Tolcapone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000455	CcSEcCtD
Tolcapone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000455	CcSEcCtD
Tolcapone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000144	0.000454	CcSEcCtD
Tolcapone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000454	CcSEcCtD
Tolcapone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000453	CcSEcCtD
Tolcapone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000453	CcSEcCtD
Tolcapone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000453	CcSEcCtD
Tolcapone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000452	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000452	CcSEcCtD
Tolcapone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000451	CcSEcCtD
Tolcapone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000451	CcSEcCtD
Tolcapone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00045	CcSEcCtD
Tolcapone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.00045	CcSEcCtD
Tolcapone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000449	CcSEcCtD
Tolcapone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000448	CcSEcCtD
Tolcapone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000447	CcSEcCtD
Tolcapone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000447	CcSEcCtD
Tolcapone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000447	CcSEcCtD
Tolcapone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000447	CcSEcCtD
Tolcapone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000446	CcSEcCtD
Tolcapone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000142	0.000446	CcSEcCtD
Tolcapone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000446	CcSEcCtD
Tolcapone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000445	CcSEcCtD
Tolcapone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000445	CcSEcCtD
Tolcapone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000443	CcSEcCtD
Tolcapone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000443	CcSEcCtD
Tolcapone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000443	CcSEcCtD
Tolcapone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000443	CcSEcCtD
Tolcapone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000442	CcSEcCtD
Tolcapone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000441	CcSEcCtD
Tolcapone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000441	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00044	CcSEcCtD
Tolcapone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00014	0.00044	CcSEcCtD
Tolcapone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000438	CcSEcCtD
Tolcapone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000438	CcSEcCtD
Tolcapone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000438	CcSEcCtD
Tolcapone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000438	CcSEcCtD
Tolcapone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000437	CcSEcCtD
Tolcapone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000139	0.000437	CcSEcCtD
Tolcapone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000436	CcSEcCtD
Tolcapone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000436	CcSEcCtD
Tolcapone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000435	CcSEcCtD
Tolcapone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000434	CcSEcCtD
Tolcapone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000433	CcSEcCtD
Tolcapone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000433	CcSEcCtD
Tolcapone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000433	CcSEcCtD
Tolcapone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000433	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000432	CcSEcCtD
Tolcapone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000432	CcSEcCtD
Tolcapone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000432	CcSEcCtD
Tolcapone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000432	CcSEcCtD
Tolcapone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000431	CcSEcCtD
Tolcapone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000431	CcSEcCtD
Tolcapone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000431	CcSEcCtD
Tolcapone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000429	CcSEcCtD
Tolcapone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000429	CcSEcCtD
Tolcapone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000429	CcSEcCtD
Tolcapone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000428	CcSEcCtD
Tolcapone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000428	CcSEcCtD
Tolcapone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000428	CcSEcCtD
Tolcapone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000427	CcSEcCtD
Tolcapone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000426	CcSEcCtD
Tolcapone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000425	CcSEcCtD
Tolcapone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000425	CcSEcCtD
Tolcapone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000425	CcSEcCtD
Tolcapone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000423	CcSEcCtD
Tolcapone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000422	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000422	CcSEcCtD
Tolcapone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000421	CcSEcCtD
Tolcapone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000421	CcSEcCtD
Tolcapone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000418	CcSEcCtD
Tolcapone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000417	CcSEcCtD
Tolcapone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000416	CcSEcCtD
Tolcapone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000416	CcSEcCtD
Tolcapone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000416	CcSEcCtD
Tolcapone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000416	CcSEcCtD
Tolcapone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000414	CcSEcCtD
Tolcapone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000414	CcSEcCtD
Tolcapone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000413	CcSEcCtD
Tolcapone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000413	CcSEcCtD
Tolcapone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000413	CcSEcCtD
Tolcapone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000412	CcSEcCtD
Tolcapone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000411	CcSEcCtD
Tolcapone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000409	CcSEcCtD
Tolcapone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000408	CcSEcCtD
Tolcapone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000408	CcSEcCtD
Tolcapone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000408	CcSEcCtD
Tolcapone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000407	CcSEcCtD
Tolcapone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000407	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000406	CcSEcCtD
Tolcapone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000405	CcSEcCtD
Tolcapone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000402	CcSEcCtD
Tolcapone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000401	CcSEcCtD
Tolcapone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.0004	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.0004	CcSEcCtD
Tolcapone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000399	CcSEcCtD
Tolcapone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000398	CcSEcCtD
Tolcapone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000397	CcSEcCtD
Tolcapone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000397	CcSEcCtD
Tolcapone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000397	CcSEcCtD
Tolcapone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000396	CcSEcCtD
Tolcapone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000396	CcSEcCtD
Tolcapone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000396	CcSEcCtD
Tolcapone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000396	CcSEcCtD
Tolcapone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000396	CcSEcCtD
Tolcapone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.000394	CcSEcCtD
Tolcapone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000392	CcSEcCtD
Tolcapone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000392	CcSEcCtD
Tolcapone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000387	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000387	CcSEcCtD
Tolcapone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000385	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000385	CcSEcCtD
Tolcapone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000384	CcSEcCtD
Tolcapone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000382	CcSEcCtD
Tolcapone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000381	CcSEcCtD
Tolcapone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000381	CcSEcCtD
Tolcapone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000381	CcSEcCtD
Tolcapone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000379	CcSEcCtD
Tolcapone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000379	CcSEcCtD
Tolcapone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000379	CcSEcCtD
Tolcapone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000379	CcSEcCtD
Tolcapone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000378	CcSEcCtD
Tolcapone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000375	CcSEcCtD
Tolcapone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000375	CcSEcCtD
Tolcapone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000375	CcSEcCtD
Tolcapone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000374	CcSEcCtD
Tolcapone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000373	CcSEcCtD
Tolcapone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00037	CcSEcCtD
Tolcapone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.00037	CcSEcCtD
Tolcapone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000369	CcSEcCtD
Tolcapone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000368	CcSEcCtD
Tolcapone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000367	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000367	CcSEcCtD
Tolcapone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000366	CcSEcCtD
Tolcapone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000366	CcSEcCtD
Tolcapone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000366	CcSEcCtD
Tolcapone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000366	CcSEcCtD
Tolcapone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000364	CcSEcCtD
Tolcapone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000364	CcSEcCtD
Tolcapone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000364	CcSEcCtD
Tolcapone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000359	CcSEcCtD
Tolcapone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000358	CcSEcCtD
Tolcapone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000354	CcSEcCtD
Tolcapone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000354	CcSEcCtD
Tolcapone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000354	CcSEcCtD
Tolcapone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000352	CcSEcCtD
Tolcapone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000352	CcSEcCtD
Tolcapone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000352	CcSEcCtD
Tolcapone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.00035	CcSEcCtD
Tolcapone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000349	CcSEcCtD
Tolcapone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000349	CcSEcCtD
Tolcapone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000348	CcSEcCtD
Tolcapone—Headache—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000347	CcSEcCtD
Tolcapone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000346	CcSEcCtD
Tolcapone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000343	CcSEcCtD
Tolcapone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000341	CcSEcCtD
Tolcapone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000338	CcSEcCtD
Tolcapone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000336	CcSEcCtD
Tolcapone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000336	CcSEcCtD
Tolcapone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000333	CcSEcCtD
Tolcapone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000332	CcSEcCtD
Tolcapone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000331	CcSEcCtD
Tolcapone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00033	CcSEcCtD
Tolcapone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00033	CcSEcCtD
Tolcapone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000329	CcSEcCtD
Tolcapone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000328	CcSEcCtD
Tolcapone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000328	CcSEcCtD
Tolcapone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000328	CcSEcCtD
Tolcapone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00032	CcSEcCtD
Tolcapone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000318	CcSEcCtD
Tolcapone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000317	CcSEcCtD
Tolcapone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000316	CcSEcCtD
Tolcapone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000315	CcSEcCtD
Tolcapone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000315	CcSEcCtD
Tolcapone—Headache—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000314	CcSEcCtD
Tolcapone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000313	CcSEcCtD
Tolcapone—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.86e-05	0.000311	CcSEcCtD
Tolcapone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.71e-05	0.000306	CcSEcCtD
Tolcapone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.67e-05	0.000305	CcSEcCtD
Tolcapone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000305	CcSEcCtD
Tolcapone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.000301	CcSEcCtD
Tolcapone—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.43e-05	0.000297	CcSEcCtD
Tolcapone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.34e-05	0.000295	CcSEcCtD
Tolcapone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.33e-05	0.000294	CcSEcCtD
Tolcapone—Rash—Ritonavir—acquired immunodeficiency syndrome	9.26e-05	0.000292	CcSEcCtD
Tolcapone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000292	CcSEcCtD
Tolcapone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000291	CcSEcCtD
Tolcapone—Headache—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.00029	CcSEcCtD
Tolcapone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000283	CcSEcCtD
Tolcapone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.91e-05	0.000281	CcSEcCtD
Tolcapone—Rash—Saquinavir—acquired immunodeficiency syndrome	8.91e-05	0.000281	CcSEcCtD
Tolcapone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.000281	CcSEcCtD
Tolcapone—Headache—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000279	CcSEcCtD
Tolcapone—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.72e-05	0.000275	CcSEcCtD
Tolcapone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.00027	CcSEcCtD
Tolcapone—Rash—Lamivudine—acquired immunodeficiency syndrome	8.5e-05	0.000268	CcSEcCtD
Tolcapone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000268	CcSEcCtD
Tolcapone—Headache—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000266	CcSEcCtD
Tolcapone—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000265	CcSEcCtD
Tolcapone—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000252	CcSEcCtD
